Home / Search / Reliance

Reliance

The patented technology analyses cell-free DNA from a simple blood sample to identify early signs of cancer and predict its tissue of origin, offering hope for faster, more accessible and scalable screening

Updated 17 hours ago

Reliance subsidiary develops AI-based blood test for early cancer detection (Pic/Special arrangement)

The 30-share BSE Sensex declined 63.65 points to 77,047.63 during initial trading. The 50-share NSE Nifty went marginally up by 16.55 points to 24,070.20

Updated 8 days ago

Reliance subsidiary develops AI-based blood test for early cancer detection (Pic/Special arrangement)
Advertisement